EvoNext Holdings S.A. (ELVAF)
EvoNext Holdings S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Reinach, BL, CH. The stock last traded at $2.15, up 0.00% on the session, giving a market capitalisation of $15.5M. On trailing twelve-month figures it carries a trailing P/E of -23.01, a net margin of 0.0%. Its beta of -0.05 implies it has historically moved less than the broad market.
EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith, and maintains its primary base of operations in Reinach, Switzerland.
EvoNext Holdings S.A. is most often compared with the following Healthcare names: